Indoco Pharma hiring On Multiple Positions
A leading pharma Company with a strong global presence and international regulatory approvals including USFDA and UKMHRA.
WALK-IN-INTERVIEWS BOISAR, MAHARASHTRA for our sterile formulations manufacturing facility in Goa (Plant II)
QUALITY ASSURANCE-Officer/Executive
Experience: 2 to 8 years
Qualification: M.PHARM/B.PHARM / MSC
Job Profile: Injectable IPQA, Validation (Process/Cleaning), Qualification, Batch Release, QMS (Investigations and Compliance) & Analytical Quality Assurance.
QUALITY CONTROL - Officer
Experience: 3 to 8 years
Qualification: BSC/MSC (Chemistry)
Job Profile: Knowledge of handling HPLC, UV, Karl Fischer, Autotitrator, GC and dissolution in sterile and non sterile.
MICROBIOLOGY - Officer
Qualification: BSC/MSC (Microbiology/Biotechnology)
Experience: 3 to 5 years
Job Profile: Experience in environment monitoring, QMS, routine & non routine analysis, PET, sterility, BET & water testing. Experience in injectable / ophthalmic products.
PRODUCTION-Executive/Officer/ Associates
Experience: 2 to 10 years
Qualification: DIPLOMA / BSC/B.PHARM/M.PHARM
Job Profile: Experience in injectable, ophthalmic products (Mfg./Filling/Washing/QMS will be considered).
CONTACT DETAILS.:
Contact No.: 7391054322
Contact No.: 7030051326
Date : 24/05/2024
TIME: 09:00 AM to 06.00 PM
Date : 25/05/2024
TIME: 09:00 am to 05.00 pm
VENUE: Hotel Freesia by Express Inn Next to Big Bazar, Ostwal Empire, Boisar-Tarapur Road, Boisar, Maharashtra.
Documents Required: Copy of Aadhar Card, PAN Card, recent increment & salary structure letter.
Note: Only candidates with experience are requested to attend the interview. Freshers can mail their CVs to the above mentioned email ids.
hiring for our #sterile #manufacturing facility in Goa
Date: May 24 to 25, 2024
Contact: indoco2@indoco.com/7030051326
#vacancies #manufacturingjobs #qualitycontrol #pharmaceuticalindustry #pharmajobs #production #sasajob #pharmajob #sasa #jobs #sarkari
Company Information
Formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) are produced and marketed by Indoco Remedies Ltd., a fully integrated pharmaceutical firm with a focus on research. We have been a major player in the Indian pharmaceutical industry for 70 years, and we also possess a solid international presence in 55 countries. The US$ 212 million Indoco corporation employs about 6000 people, including more than 400 highly qualified scientists.
We have 11 production facilities, of which 4 are for APIs and 7 are for final doses. These are backed by a clinical research organization in Hyderabad and a cutting-edge R&D center located in Rabale, Navi Mumbai. The highest regulatory requirements are met by our manufacturing facilities, which adhere to WHO-cGMP principles and have received approval from a number of regulatory bodies, including the USFDA, UK-MHRA, TGA-Australia, SAHPRA-South Africa, NDA-Uganda, TMDA-Tanzania, MOH-Ukraine, PPB-Kenya, DPML-Ivory Coast, etc. Indoco has expanded its reach into global markets and now provides comprehensive solutions to generic firms across the globe, including product development, manufacturing, and supply of finished dosages, intermediates, and APIs. We offer a wide range of goods supported by Drug Master Files (DMFs), ANDAs, and eCTD dossiers.
Consistent growth in the company's domestic and international operations will be ensured by its expertise in research and development, backward integration in API in chosen products, own CRO setup, proficiency in finished dosage manufacture, and a robust client base.
Perspective To raise people's standard of living by providing the best possible goods at reasonable costs To guarantee that maintaining quality becomes second nature, a dedication that is evident across the entire process—from employee relations to production, testing, and marketing— to become an internationally renowned research-based business with presence on every continent
Mission: To remain a pharmaceutical company that prioritizes quality and research. to adopt and integrate current good manufacturing practices (cGMP) while paying close attention to environmental safety To strengthen the confidence that the medical community has fostered to celebrate company accomplishments and communicate management goals with staff
The USFDA successfully completes its examination of Indoco's IAS division and API Kilo Lab manufacturing facility with no observations. 'Digital Health Innovator Company of the Year' honor goes to Indoco A fully owned subsidiary of Indoco Remedies, Warren Remedies Private Limited, starts producing Pharmaceutical Intermediates and APIs for sale. Oral care products were introduced by Indoco Remedies Limited's 100% subsidiary, Warren Remedies Private Limited. Indoco Remedies acknowledges the closure of inspection at its state-of-the-art plant I in Goa after receiving an EIR from the USFDA.
The "IDMA Margi Patel Choksi Memorial Best Patent Awards 2019–2021" are given to Indoco. Diclofenac and Quetiapine are the two formulation patents for which Indoco received the IDMA Formulations Best Patent Award 2018-19. For one international and two Indian patentsOlopatadine, Gliclazide, and Brinzolamide Ophthalmic Solution
Indoco wins the IDMA Formulations Patent Award 2017–18. For five API Process Patents (four Indian and one EU) in 2018, Indoco is awarded the IDMA Best Indian Patent Award 2016–17. For four API Process Patents, Indoco was awarded the 2017 "IDMA Best Patent Award." Indoco received recognition for three international patents in 2016 with the "IDMA Best Patent Award."
In the bulk drugs/API area, PHARMEXCIL presented Indoco with the "Best Patent Award" in 2016. For its manufacturing process of betaxolol hydrochloride API, Indoco received the IDMA Patent Appreciation Award in 2015. Indoco's European Patent application for Lacosamide is approved. 2015 saw Indoco get a "Certificate of Appreciation" (Bulk Drugs). 2014's 52nd IDMA Award Function saw Indoco earn the "Patent Appreciation Award."
0 Comments